What's New

NextPharma’s Product Development Services division is pleased to announce that its’ Sterile Product Development Centre (SPDC) in Braine-l’Alleud, Belgium opened officially on 1st October 2008. 

Initially, services provided will be formulation development of products to OEL 2/Saftbridge level 2 and from January 2009 to OEL4/Safebridge level 4 (including Cytotoxics). Following on from this, in the second quarter of 2009, we will be providing GMP production of clinical trials material (typically up to 6,000 vials) in support of our existing commercial operations.

The opening of this unit is a significant milestone in the expansion of our services.

Click here for further information.

NextPharma Technologies Enters Partnership Agreement with Aseptic Technologies

Under this agreement NextPharma will sub-contract the filling of vials to Aseptic Technologies (at their site near to Brussels) for those NextPharma customers wishing to access this new technology – which involves the aseptic filling of vials, based on a completely closed system and using pre-sterilised plastic vials.

Read more....

NextPharma Technologies Announces the Opening of a Sales Representative Office in Japan

The decision to expand services to Japan has been taken in relation to NextPharma’s growing business in Japan – the World’s second largest pharmaceutical market.

Click here for our press release.